Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

(ANTX) logo

About (ANTX) Stock (NYSE:ANTX)

Advanced Chart

Key Stats

Today's Range
$1.22
$1.26
50-Day Range
N/A
52-Week Range
$0.87
$3.07
Volume
83,337 shs
Average Volume
368,285 shs
Market Capitalization
$32.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
Consensus Rating
Hold

Company Overview

Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

ANTX Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI
Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

(ANTX) (NYSE:ANTX) issued its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.48) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.59) by $0.11.

(ANTX) (ANTX) raised $69 million in an initial public offering (IPO) on Friday, March 25th 2022. The company issued 4,600,000 shares at $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Broadcom (AVGO), NVIDIA (NVDA), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/13/2024
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:ANTX
Previous Symbol
NASDAQ:ANTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.50
High Stock Price Target
$2.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+38.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.73 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.26

Miscellaneous

Free Float
23,667,000
Market Cap
$32.42 million
Optionable
Not Optionable
Beta
0.15
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:ANTX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners